Japan, Jan. 27 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'UNIVERSAL MODULAR TEST FIXTURE.' Other related details are as follows:
Application Number: JP,2024-186776
Category (FI): G01N3/04@P,G01N3/08
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 23, 2024
Publication Date: Jan. 9, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
